Search research articles
Contact Us
Filters
Showing results (11-20 of 63) with videos related to
Page
of 7
Sort By:
Journal of Cutaneous Medicine and Surgery
|
February 5, 2021
Superficial Granulomatous Pyoderma Gangrenosum Involving the Face: A Case Series of Five Patients and a Review of the Literature
Eran Shavit, Michael Cecchini, James J Limacher, et al.
The Oncologist
|
March 17, 2021
Publication Bias in Gastrointestinal Oncology Trials Performed over the Past Decade
Gabrielle W Peters, Weiwei Tao, Wei Wei, et al.
The Lancet. Oncology
|
January 6, 2018
Introduction to the Yale Precision Medicine Tumor Board
Michael Cecchini, Zenta Walther, Jeffrey L Sklar, et al.
Annals of Surgical Oncology
|
May 30, 2025
A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Adenocarcinoma with Peritoneal Metastasis
Justin M Bader, Ava Ospina, Sean Liu, et al.
The Lancet. Oncology
|
January 6, 2018
Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes
Michael Cecchini, Zenta Walther, Jeffrey L Sklar, et al.
BMC Cancer
|
July 15, 2016
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study
Pashtoon M Kasi, Daisuke Kotani, Michael Cecchini, et al.
Dermatology and Therapy
|
April 20, 2026
Efficacy and Safety of the PD-1 Agonist JNJ-67484703 in Participants with Atopic Dermatitis: Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial Results
Michael Cecchini, Bartlomiej Kwiek, Fang Liu-Walsh, et al.
Cancer Metastasis Reviews
|
April 23, 2026
Evolving therapeutics in colorectal cancer peritoneal metastases
Justin M Bader, Nicole Aguirre, Kurt S Schultz, et al.
The Lancet. Oncology
|
March 4, 2021
Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan
Joanna A Gibson, Karin E Finberg, ILKe Nalbantoglu, et al.
Journal for Immunotherapy of Cancer
|
September 11, 2025
High MGMT expression identifies aggressive colorectal cancer with distinct genomic features and immune evasion properties
Janie Yue Zhang, Barani Kumar Rajendran, Shruti S Desai, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 63) with videos related to
Sort By:
Page
of 7
Journal of Cutaneous Medicine and Surgery
|
February 5, 2021
Superficial Granulomatous Pyoderma Gangrenosum Involving the Face: A Case Series of Five Patients and a Review of the Literature
Eran Shavit, Michael Cecchini, James J Limacher, et al.
The Oncologist
|
March 17, 2021
Publication Bias in Gastrointestinal Oncology Trials Performed over the Past Decade
Gabrielle W Peters, Weiwei Tao, Wei Wei, et al.
The Lancet. Oncology
|
January 6, 2018
Introduction to the Yale Precision Medicine Tumor Board
Michael Cecchini, Zenta Walther, Jeffrey L Sklar, et al.
Annals of Surgical Oncology
|
May 30, 2025
A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Adenocarcinoma with Peritoneal Metastasis
Justin M Bader, Ava Ospina, Sean Liu, et al.
The Lancet. Oncology
|
January 6, 2018
Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes
Michael Cecchini, Zenta Walther, Jeffrey L Sklar, et al.
BMC Cancer
|
July 15, 2016
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study
Pashtoon M Kasi, Daisuke Kotani, Michael Cecchini, et al.
Dermatology and Therapy
|
April 20, 2026
Efficacy and Safety of the PD-1 Agonist JNJ-67484703 in Participants with Atopic Dermatitis: Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial Results
Michael Cecchini, Bartlomiej Kwiek, Fang Liu-Walsh, et al.
Cancer Metastasis Reviews
|
April 23, 2026
Evolving therapeutics in colorectal cancer peritoneal metastases
Justin M Bader, Nicole Aguirre, Kurt S Schultz, et al.
The Lancet. Oncology
|
March 4, 2021
Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan
Joanna A Gibson, Karin E Finberg, ILKe Nalbantoglu, et al.
Journal for Immunotherapy of Cancer
|
September 11, 2025
High MGMT expression identifies aggressive colorectal cancer with distinct genomic features and immune evasion properties
Janie Yue Zhang, Barani Kumar Rajendran, Shruti S Desai, et al.
Page
of 7